Newer trends in the management of genital herpes

Indian Journal of Dermatology, Venereology and Leprology

Volumn 75, Issue 6, 2009, Pages 566-574

  Nath, Amiya K ^a   Thappa, Devinder Mohan ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acyclovir; Famciclovir; Genital herpes; HIV; Pregnancy; Valacyclovir

Indexed keywords

ACICLOVIR; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; PENCICLOVIR; RESIQUIMOD; VALACICLOVIR; VIRUS DNA; VIVAGEL;

ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; CESAREAN SECTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL HERPES; HERPES SIMPLEX VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; NEWBORN INFECTION; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PREGNANCY; QUALITY OF LIFE; RECURRENT INFECTION; REVIEW; SEROLOGY; SEXUALITY; TREATMENT DURATION; VIRUS CULTURE; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; COMMUNICABLE DISEASE CONTROL; FEMALE; HERPES GENITALIS; HUMANS; INDIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 70450192088     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.57716     Document Type: Review

References (25)

1. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol 2007;57:737-63; quiz 764-766
2. Kaliaperumal K. Recent advances in management of genital ulcer disease and anogenital warts. Dermatol Ther 2008;21:196-204.
3. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007;370:2127-2137
4. Gupta S, Kumar B. Genital herpes simplex infections. In: Kumar B, Gupta S, editors. Sexually transmitted infections. New Delhi: Elsevier; First edition. 2005. p. 191-214.
5. Sundharam JA. Herpes Genitalis. In: Sharma VK, editor. Sexually Transmitted Diseases and AIDS. First edition. New Delhi: Viva books Pvt Ltd; 2003. p. 259-272
6. Strick LB, Wald A. Diagnostics for herpes simplex virus: is PCR the new gold standard. Mol Diagn Ther 2006;10:17-28.
7. Brown ZA, Gardella C, Wald A, Morrow RA, Corey L. Genital herpes complicating pregnancy. Obstet Gynecol 2005;106:845-856
8. CDC. Sexually transmitted diseases treatment guidelines, MMWR 2006: 55: No..
9. Gupta R, Wald A. Genital herpes: Antiviral therapy for symptom relief and prevention of transmission. Expert Opin Pharmacother 2006;7:665-675
10. Martinez V, Caumes E, Chosidow O. Treatment to prevent recurrent genital herpes. Curr Opin Infect Dis 2008;21:42-48
11. Tyring S, Berger T, Yen-Moore A, Tharp M, Hamed K. Singleday therapy for recurrent genital herpes. Am J Clin Dermatol 2006;7:209-211
12. Romanowski B, Marina RB, Roberts JN; Valtrex HS230017 Study Group. Patients. preference of valacyclovir once-daily suppressive therapy versus twice daily episodic therapy for recurrent genital herpes. Sex Transm Dis 2003;30:226-231
13. Strick LB, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis 2006;43:347-356
14. Stone KM, Reiff-Eldridge R, White AD, Cordero JF, Brown Z, Alexander ER, et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol 2004;70:201-207
15. Andrews WW, Kimberlin DF, Whitley R, Cliver S, Ramsey PS, Deeter R. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol 2006;194:774-781 (Pubitemid 43333153)
16. Freij BJ. Management of neonatal herpes simplex virus infections. Indian J Pediatr 2004;71:921-926
17. Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: A randomized clinical trial. Obstet Gynecol 2006;108:141-147
18. Little SE, Caughey AB. Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: A costeffectiveness analysis. Am J Obstet Gynecol 2005;193:1274-1279
19. Reyes M, Shaik NS, Graber JM, Nisenbaum R, Wetherall NT, Fukuda K, et al. Task Force on Herpes Simplex Virus Resistance. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003;163:76-80.
20. Gottlieb SL, Douglas JM Jr, Foster M, Schmid DS, Newman DR, Baron AE, et al. Project RESPECT Study Group. Incidence of herpes simplex virus type 2 infection in sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004;190:1059-1067
21. Rajcáni J, Durmanová V. Developments in herpes simplex virus vaccines: Old problems and new challenges. Folia Microbiol (Praha) 2006;51:67-85.
22. Bernstein DI, Aoki FY, Tyring SK, Stanberry LR, St-Pierre C, Shafran SD, et al. Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine. Clin Infect Dis 2005;40:1271-1281
23. Chakrabarty A, Pang KR, Wu JJ, Narvaez J, Rauser M, Huang DB, et al. Emerging therapies for herpes viral infections (types 1-8). Expert Opin Emerg Drugs 2004;9:237-256
24. Kaufman HE, Varnell ED, Gebhardt BM, Thompson HW, Atwal E, Rübsamen-Waigmann H, et al. Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection. J Ocul Pharmacol Ther 2008;24:34-42.
25. Zhang X, Chentoufi AA, Dasgupta G, Nesburn AB, Wu M, Zhu X, et al. A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8(+) T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunol 2009;2:129-143